BX Swiss TOP 30 CHF
1.270,79
PKT
+9,69
PKT
+0,77
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
05.04.16 | Roche overweight | Morgan Stanley | |
05.04.16 | UBS Underperform | BNP PARIBAS | |
05.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.04.16 | Richemont Outperform | Bernstein Research | |
01.04.16 | Roche overweight | JP Morgan Chase & Co. | |
01.04.16 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
01.04.16 | Swiss Re buy | Jefferies & Company Inc. | |
01.04.16 | Nestlé Sell | Goldman Sachs Group Inc. | |
01.04.16 | Novartis Neutral | UBS AG | |
31.03.16 | Roche buy | UBS AG | |
31.03.16 | Richemont buy | Kepler Cheuvreux | |
31.03.16 | Roche overweight | JP Morgan Chase & Co. | |
31.03.16 | UBS Neutral | JP Morgan Chase & Co. | |
31.03.16 | UBS Neutral | JP Morgan Chase & Co. | |
31.03.16 | UBS buy | Citigroup Corp. | |
30.03.16 | Swiss Re buy | Société Générale Group S.A. (SG) | |
30.03.16 | Zurich Insurance Hold | Jefferies & Company Inc. | |
30.03.16 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
29.03.16 | Zurich Insurance overweight | Barclays Capital | |
29.03.16 | UBS overweight | Barclays Capital | |
29.03.16 | Swiss Re Equal weight | Barclays Capital | |
29.03.16 | Novartis Neutral | Citigroup Corp. | |
29.03.16 | Richemont buy | UBS AG | |
24.03.16 | UBS Halten | Independent Research GmbH | |
24.03.16 | UBS Equal-Weight | Morgan Stanley | |
24.03.16 | Richemont Neutral | Credit Suisse Group | |
24.03.16 | UBS buy | Goldman Sachs Group Inc. | |
24.03.16 | Holcim buy | Goldman Sachs Group Inc. | |
24.03.16 | UBS Neutral | UBS AG | |
23.03.16 | Holcim Neutral | BNP PARIBAS | |
23.03.16 | Roche buy | UBS AG | |
23.03.16 | Swiss Re buy | Deutsche Bank AG | |
22.03.16 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
22.03.16 | UBS Neutral | Goldman Sachs Group Inc. | |
22.03.16 | UBS Conviction Buy List | Goldman Sachs Group Inc. | |
22.03.16 | Novartis buy | HSBC | |
22.03.16 | Roche Hold | HSBC | |
18.03.16 | Richemont overweight | Morgan Stanley | |
18.03.16 | Holcim Neutral | JP Morgan Chase & Co. | |
18.03.16 | Holcim neutral | Bernstein Research |